You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Prostate cancer discovery opens door to more tailored treatments
- 2. Prostate cancer, race and the need for tests | Letters
- 3. Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Status: Opinion
- 4. Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
- 5. Revealing propionate metabolism-related genes in glioblastoma and investigating their underlying mechanisms
- 6. Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care
- 7. IV medication could be taken orally for range of cancer, Alzheimer's treatments
- 8. Solid subtype of adenoid cystic carcinoma of the breast with multiple distant metastases: a case report and literature review
- 9. Development and validation of a preoperative magnetic resonance imaging-based and machine learning model for the noninvasive differentiation of intracranial glioblastoma, primary central nervous system lymphoma and brain metastases: a retrospective analysis
- 10. Three-dimensional gene hubs may promote brain cancer
Last updated at 20:36 GMT
Hot News Makers
Health/Pharma Companies
-
487711.58
-
185507.96
-
143459.26
-
36385.11
-
19070.46
-
17079.81
-
11525.38
-
10804.23
-
10192.01
-
9979.90
Drugs, Treatments, Trials
-
35680.72
-
17698.13
-
12103.95
-
12103.61
-
7631.83
-
7565.77
-
4090.34
-
3874.59
-
3768.19
-
3398.33
Last updated at 20:10 GMT
